Mary Beth DeLena is the Chief Legal Officer and Secretary of City Therapeutics. Ms. DeLena has more than 25 years of legal and corporate experience in the life sciences industry, spanning early research and development through commercial launch and execution. Prior to joining City, she served as Chief Legal Officer and Secretary of Paragon Therapeutics, where she oversaw governance, licensing, alliance management and intellectual property. She previously served as General Counsel and Secretary of PepGen Inc.

Ms. DeLena spent more than 15 years at Alnylam Pharmaceuticals, most recently as Senior Vice President, Deputy General Counsel and Assistant Secretary, during which time the company advanced five RNAi therapeutics toward FDA approval. During her tenure at Alnylam, she advised senior leadership on multiple transformational transactions, including a $2 billion strategic financing collaboration with Blackstone, an $800 million eye and CNS collaboration with Regeneron, and a $700 million rare disease collaboration with Sanofi Genzyme. Earlier in her career, she served as Vice President, Legal and Secretary at Praecis Pharmaceuticals, and began her legal career at Skadden, Arps, Slate, Meagher & Flom LLP. Ms. DeLena earned a J.D. from Northeastern University School of Law and a bachelor’s degree in english from Trinity College.